OncoHost Achieves Gold Winner Status at 2025 Merit Awards for R&D Excellence

OncoHost Recognized with Gold at 2025 Merit Awards

OncoHost, a trailblazer in precision medicine, proudly announced its recognition as a Gold Winner at the esteemed 2025 Merit Awards. This accolade highlights the company's notable advancements in research and development, particularly concerning its game-changing PROphet® platform. This award serves as a testament to OncoHost's commitment to improving patient outcomes through cutting-edge technology.

Acknowledging Innovation

The Merit Awards is an annual program that celebrates the innovative endeavors of companies and individuals who make significant contributions across various industries. OncoHost was specifically celebrated in the Research and Development category due to its revolutionary work in utilizing artificial intelligence for precision medicine. The PROphet® platform employs bioinformatics and machine learning to analyze the plasma proteome of patients, delivering both predictive insights and biological explanations that empower oncologists.

Dr. Ofer Sharon, CEO of OncoHost, expressed his enthusiasm regarding this award, stating, "Receiving the Gold in Research and Development from the Merit Awards confirms the ambitious scientific initiatives taking place at OncoHost." He further emphasized that this recognition strengthens their mission to equip oncologists with predictive tools, ultimately ensuring each patient receives optimal treatment options.

Groundbreaking R&D Framework

OncoHost’s research framework combines multiple disciplines, including machine learning, proteomics, systems biology, and translational medicine. Their multidisciplinary team, composed of theoretical physicists, molecular biologists, algorithm developers, and clinicians, collaborates to explore treatment resistance mechanisms and extends clinical indications.

The pinnacle of their innovation is the PROphetNSCLC™, an AI-driven liquid biopsy test that informs first-line immunotherapy decisions for metastatic non-small cell lung cancer (NSCLC). Following the success of this test, OncoHost is in advanced clinical development phases for PROphetRCC™ (targeted at renal cell carcinoma) and PROphetMELANOMA™ (developed for melanoma cases).

In a significant development for patient safety, OncoHost is also expanding its clinical utility by introducing PROphetirAE™, a predictive tool designed to identify patients at risk of severe immune-related adverse events prior to commencing treatment. This initiative aims to support a personalized and proactive care approach, ensuring patients receive treatments tailored to their unique circumstances and minimizing avoidable risks.

A Continuous Journey in Precision Oncology

This award underscores OncoHost's relentless pursuit of advancing precision oncology. With a pipeline of promising clinical developments, a robust intellectual property portfolio, and increasing visibility within peer-reviewed medical literature, OncoHost is steadfast in its commitment to developing biomarker-driven tools that enhance informed cancer care.

About OncoHost

Operating from Binyamina, Israel, and Cary, North Carolina, OncoHost is a pioneering technology company focused on transforming the precision medicine landscape to improve patient outcomes. The company's PROphet® platform offers a sophisticated plasma-based proteomic analysis, specifically targeting NSCLC, and provides essential guidance for healthcare providers in determining the best first-line immunotherapy strategy for individual patients. This user-friendly tool not only streamlines treatment decisions but also significantly impacts overall survival rates.

Backed by an experienced team of leaders and supported by extensive clinical trials with over 40 sites and 1,700 patients globally, OncoHost stands poised to elevate precision diagnostics and biomarker development to new heights in healthcare. For more information, you can visit OncoHost’s website or follow them on social media platforms such as LinkedIn, Twitter, Facebook, and YouTube.

About the Merit Awards

The Merit Awards program honors outstanding achievements in various sectors, shining a spotlight on innovative practices and leadership that create a measurable impact. By recognizing those who redefine excellence through inventive and transformative strategies, the Merit Awards seeks to champion the best in business and industry.

For more details, explore the official Merit Awards website at merit-awards.com.